Esomeprazole for preventing radiation-induced esophagitis
Treatments studied
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study tests whether a common heartburn medicine (esomeprazole) can help prevent or reduce painful swallowing caused by radiation for lung cancer. If you have stage 3 non-small cell lung cancer and are getting chemo and chest radiation, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have stage 3 non-small cell lung cancer.
- You are scheduled to get both chemotherapy and radiation to your chest.
- You do not have severe swallowing problems now.
- You have not had radiation to your chest in the last 2 years.
- You are not taking certain other medicines (like clopidogrel, methotrexate, or digoxin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a proton pump inhibitor (a common heartburn drug) before and during radiation therapy for lung cancer can protect the esophagus from damage. It may help people who are about to start radiation for any stage of lung cancer.
This Phase 3 trial tests whether giving preventive (prophylactic) radiation reduces cancer coming back in people with early esophagus cancer after standard chemoradiation. It may help by lowering the chance that microscopic cancer spreads to nearby areas.
This trial studies whether proton therapy can better treat early-to-mid stage esophagus cancer while aiming to reduce side effects to nearby organs. Proton therapy uses a targeted type of radiation, and participants are also checked to be eligible for curative surgery.
This trial tests if a special nutritional supplement (immunonutrition) can lower the risk of severe throat and chest irritation (esophagitis) caused by radiation therapy for lung cancer. You may qualify if you are about to start chest radiation and can eat normally.
This trial tests a medication (esomeprazole) given through an IV to help protect the stomach lining after surgery. It is for patients in the intensive care unit (ICU) for at least 3 days.
This study tests a new pre-surgery treatment plan that combines chemotherapy with focused, shorter-course radiation for esophagus or stomach-where-it-meets-the-esophagus (GEJ) adenocarcinoma. The goal is to shrink the tumor before surgery and improve treatment outcomes.
Hear when a new Locally Advanced Lung Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.